Annual Current Assets
$407.50 M
+$43.44 M+11.93%
December 31, 2023
Summary
- As of February 8, 2025, RCKT annual total current assets is $407.50 million, with the most recent change of +$43.44 million (+11.93%) on December 31, 2023.
- During the last 3 years, RCKT annual current assets has fallen by -$79.85 million (-16.38%).
- RCKT annual current assets is now -16.38% below its all-time high of $487.35 million, reached on December 31, 2020.
Performance
RCKT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$241.75 M
-$50.97 M-17.41%
September 30, 2024
Summary
- As of February 8, 2025, RCKT quarterly total current assets is $241.75 million, with the most recent change of -$50.97 million (-17.41%) on September 30, 2024.
- Over the past year, RCKT quarterly current assets has dropped by -$205.11 million (-45.90%).
- RCKT quarterly current assets is now -50.39% below its all-time high of $487.35 million, reached on December 31, 2020.
Performance
RCKT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
RCKT Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +11.9% | -45.9% |
3 y3 years | -16.4% | -45.9% |
5 y5 years | +94.9% | -45.9% |
RCKT Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +11.9% | -45.9% | at low |
5 y | 5-year | -16.4% | +32.4% | -50.4% | +3.7% |
alltime | all time | -16.4% | >+9999.0% | -50.4% | +6487.3% |
Rocket Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $241.75 M(-17.4%) |
Jun 2024 | - | $292.73 M(-15.2%) |
Mar 2024 | - | $345.16 M(-8.7%) |
Dec 2023 | $188.12 M(+0.2%) | $378.22 M(-15.4%) |
Sep 2023 | - | $446.87 M(+43.2%) |
Jun 2023 | - | $312.07 M(-7.7%) |
Mar 2023 | - | $338.03 M(-7.1%) |
Dec 2022 | $187.75 M(+78.9%) | $364.06 M(+17.0%) |
Sep 2022 | - | $311.13 M(-4.5%) |
Jun 2022 | - | $325.77 M(-7.9%) |
Mar 2022 | - | $353.85 M(-9.7%) |
Dec 2021 | $104.96 M(+1.4%) | $392.06 M(-7.8%) |
Sep 2021 | - | $425.07 M(-1.2%) |
Jun 2021 | - | $430.43 M(-8.8%) |
Mar 2021 | - | $471.82 M(-3.2%) |
Dec 2020 | $103.48 M(+60.8%) | $487.35 M(+109.0%) |
Sep 2020 | - | $233.21 M(-8.7%) |
Jun 2020 | - | $255.44 M(-8.7%) |
Mar 2020 | - | $279.81 M(-9.1%) |
Dec 2019 | $64.37 M | $307.75 M(+25.3%) |
Sep 2019 | - | $245.59 M(-6.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $263.63 M(+32.1%) |
Mar 2019 | - | $199.62 M(-4.5%) |
Dec 2018 | $42.23 M(+5676.3%) | $209.09 M(+62.3%) |
Sep 2018 | - | $128.82 M(-4.3%) |
Jun 2018 | - | $134.61 M(-27.2%) |
Mar 2018 | - | $184.83 M(+82.9%) |
Dec 2017 | $731.00 K(-43.7%) | $101.05 M(-2.7%) |
Sep 2017 | - | $103.87 M(-5.4%) |
Jun 2017 | - | $109.82 M(-5.8%) |
Mar 2017 | - | $116.63 M(-9.1%) |
Dec 2016 | $1.30 M(+35.9%) | $128.35 M(-7.6%) |
Sep 2016 | - | $138.92 M(+40.8%) |
Jun 2016 | - | $98.70 M(-4.4%) |
Mar 2016 | - | $103.25 M(-8.1%) |
Dec 2015 | $955.00 K(-48.4%) | $112.37 M(-5.8%) |
Sep 2015 | - | $119.22 M(+141.0%) |
Jun 2015 | - | $49.48 M(-7.4%) |
Mar 2015 | - | $53.44 M(+1356.1%) |
Dec 2014 | $1.85 M(>+9900.0%) | $3.67 M(-50.6%) |
Sep 2014 | - | $7.43 M(-42.2%) |
Dec 2013 | $4000.00(0.0%) | $12.86 M |
Dec 2012 | $4000.00 | - |
FAQ
- What is Rocket Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual current assets year-on-year change?
- What is Rocket Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly current assets year-on-year change?
What is Rocket Pharmaceuticals annual total current assets?
The current annual current assets of RCKT is $407.50 M
What is the all time high annual current assets for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual total current assets is $487.35 M
What is Rocket Pharmaceuticals annual current assets year-on-year change?
Over the past year, RCKT annual total current assets has changed by +$43.44 M (+11.93%)
What is Rocket Pharmaceuticals quarterly total current assets?
The current quarterly current assets of RCKT is $241.75 M
What is the all time high quarterly current assets for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly total current assets is $487.35 M
What is Rocket Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, RCKT quarterly total current assets has changed by -$205.11 M (-45.90%)